In the last trading session, 0.14 million shares of the Trinity Biotech Plc ADR (NASDAQ:TRIB) were traded, and its beta was 1.03. Most recently the company’s share price was $0.83, and it changed around $0.01 or 0.67% from the last close, which brings the market valuation of the company to $9.39M. TRIB currently trades at a discount to its 52-week high of $3.55, offering almost -327.71% off that amount. The share price’s 52-week low was $0.75, which indicates that the current value has risen by an impressive 9.64% since then. We note from Trinity Biotech Plc ADR’s average daily trading volume that its 10-day average is 0.21 million shares, with the 3-month average coming to 195.55K.

Trinity Biotech Plc ADR (NASDAQ:TRIB) trade information

Instantly TRIB has showed a green trend with a performance of 0.67% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8800 on recent trading dayincreased the stock’s daily price by 5.68%. The company’s shares are currently down -6.16% year-to-date, but still down -1.31% over the last five days. On the other hand, Trinity Biotech Plc ADR (NASDAQ:TRIB) is -7.98% down in the 30-day period. We can see from the shorts that 94129.0 shares have been sold at a short interest cover period of 0.43 day(s).

Trinity Biotech Plc ADR (TRIB) estimates and forecasts

Trinity Biotech Plc ADR share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -73.18 percent over the past six months and at a 48.37% annual growth rate that is well above the industry average of 11.90%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 9.90%.

TRIB Dividends

Trinity Biotech Plc ADR’s next quarterly earnings report is expected to be released in February. The average dividend yield for the past five years averaged 1.19 per year.